drugset / Trial / NCT02667106
Phase I Pharmacokinetic Study of RX0041-2
NaSingle-groupOpen-labelBasic science
Summary
This Phase I study is to examine the systemic pharmacokinetics of RX0041-002 following acute, topical, intranasal administration to healthy male and female volunteers.
Timeline
- Start
- 2015-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RX0041-2 | Unknown | — | Topical |
Indications
No indication recorded.